Autolus Therapeutics is listing its ADR shares on the Nasdaq exchange, and Jefferies Financial Group has issued research reports on the company.
2 reports, 1 independent
Updated Aug 8
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Autolus Therapeutics is listing its ADR shares on the Nasdaq exchange, and Jefferies Financial Group has issued research reports on the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Autolus Therapeutics
company in London, United Kingdom
Nothing else this week.
-
Jefferies Financial Group
American financial services company
-
Nasdaq
American fully electronic stock exchange
Related events
- Jefferies Financial Group initiated analyst coverage on IperionX Limited Sponsored ADR stock on October 1, 2026.
- VOR stock trades on the Nasdaq electronic exchange, and analyst reports are affecting company valuation.
- Jefferies Financial Group increased its price target for Procter & Gamble stock, according to MarketScreener.
- BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.
- Jefferies Financial Group cut Icade's stock rating to underperform on October 15, 2026.